In this file
Changing platforms involves a new care relationship as well as a new payment arrangement. A successful sign-up does not automatically cancel the previous service or authorize the same prescription at the new one.
The answer below follows Hers’s published documents. It separates the relevant policy or service claim from the details that still require confirmation for an individual account, prescription, or insurance plan.
What the documents establish
Hers describes an intake and clinician review for patients already using GLP-1 medication. It says care may sometimes continue without starting over, but that is not a guarantee of the same drug, prescription, price, or availability. The receiving clinician must evaluate the treatment history.
The detail that changes the decision
The current FAQ describes access to approved GLP-1 products and requires clinician assessment for new or transferring patients. A transfer request is not an automatic continuation of a previous prescription. Ask the receiving clinician how the medication history and follow-up needs will be reviewed.
The membership page lists $39 for the first month followed by $149 per month, excluding medication. Medicine is billed separately under the selected plan. Build the budget from both charges and confirm the medication’s own renewal price rather than using the membership promotion as the total cost.
Hers explains that cancelling membership also ends active medication plans and platform care, while cancelling medication alone leaves membership active. A patient who wants all future payments stopped should identify both components. The remaining financial obligation under a prepaid medication plan still needs to be checked.
Use these checks before acting
Put the request in writing when a payment, cancellation, or order stage is involved. The response should identify your actual plan and the date the change will take effect.
- Provide the current label and relevant treatment history.
- Confirm the new product and full recurring cost.
- Stop old renewals separately after clarifying continuity of care.
Reach the appropriate team
A general patient telephone number or email was not established from the documents selected for this file. We leave that gap visible rather than reconstructing a masked address or publishing an unrelated department’s number.
A general patient phone and email were not established from the selected documents. Start with the official website and its patient-support navigation.
For account navigation and supporting documents, use the Hers contact section and then the provider’s own secure system. A general support agent may need to route prescribing or pharmacy questions to another professional.
Keep the medical and financial decisions separate
An approved cancellation request does not provide instructions for stopping a medicine. An insurance estimate does not determine which treatment is appropriate. Ask the treating clinician about continuity of care, and ask the business about the specific payment or order.
If instructions or access are unclear, seek clarification before improvising a prescription change. For urgent symptoms, use appropriate local medical care rather than waiting in a routine account-support queue.
Continue the same inquiry
The Hers provider file places this question alongside the company’s care model, price, prescription description, and cancellation terms. Read those details together so that one helpful answer does not hide another unresolved part of the plan.
The subscription and refund guide explains why ending future billing, reversing a payment, and stopping a pharmacy order are separate requests.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- Hers weight-loss FAQ ↗Provider-published information · Checked September 22, 2026
- Hers weight-loss membership ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- MedlinePlus: semaglutide injection ↗Medical reference · Checked September 22, 2026
- MedlinePlus: tirzepatide injection ↗Medical reference · Checked September 22, 2026